Cargando…
Circulating Tumor Cell Analysis in Preclinical Mouse Models of Metastasis
The majority of cancer deaths occur because of metastasis since current therapies are largely non-curative in the metastatic setting. The use of in vivo preclinical mouse models for assessing metastasis is, therefore, critical for developing effective new cancer biomarkers and therapies. Although a...
Autores principales: | Kitz, Jenna, Lowes, Lori E., Goodale, David, Allan, Alison L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023422/ https://www.ncbi.nlm.nih.gov/pubmed/29710776 http://dx.doi.org/10.3390/diagnostics8020030 |
Ejemplares similares
-
EMT-independent detection of circulating tumor cells in human blood samples and pre-clinical mouse models of metastasis
por: Kitz, Jenna, et al.
Publicado: (2021) -
Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer
por: Lowes, Lori E., et al.
Publicado: (2016) -
Reduced Zeb1 Expression in Prostate Cancer Cells Leads to an Aggressive Partial-EMT Phenotype Associated with Altered Global Methylation Patterns
por: Kitz, Jenna, et al.
Publicado: (2021) -
Recent Advances in the Molecular Characterization of Circulating Tumor Cells
por: Lowes, Lori E., et al.
Publicado: (2014) -
Triple-Negative Primary Breast Tumors Induce Supportive Premetastatic Changes in the Extracellular Matrix and Soluble Components of the Lung Microenvironment
por: Medeiros, Braeden, et al.
Publicado: (2020)